Therapeutic developments in pancreatic cancer: current and future perspectives | Nature Reviews Gastroenterology & Hepatology
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial - The Lancet
Paricalcitol for Cancer of Pancreas Clinical Trial | Power
Treatment of Metastatic Pancreatic Adenocarcinoma: A Review
Current Standards and Novel Treatment Options for Metastatic Pancreatic Adenocarcinoma
Novel Strategies on the Horizon for Metastatic Pancreatic Cancer
Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial | PLOS ONE
Treatment landscape of metastatic pancreatic cancer - Cancer Treatment Reviews
Clinical Studies in the Second Line Setting of Advanced Pancreatic Cancer: Are We Making Any Progress?
Frontiers | Upcoming Revolutionary Paths in Preclinical Modeling of Pancreatic Adenocarcinoma | Oncology
Novel Strategies on the Horizon for Metastatic Pancreatic Cancer
Promising New Pancreatic Cancer Clinical Trial Now at Summit Cancer Centers
Phase 1 Trials in Pancreatic Cancer
Metastatic Pancreatic Cancer Clinical Trials - Massive Bio
Consensus guidelines in pancreatic cancer treatment | Advances in Pancreatic Cancer Treatment
The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives | Signal Transduction and Targeted Therapy
ASCO GI 2021: Results From the Phase 3 POLO Trial
Fluorouracil for Cancer of Pancreas Clinical Trial | Power
Cancers | Free Full-Text | Clinical Trials Targeting the Stroma in Pancreatic Cancer: A Systematic Review and Meta-Analysis | HTML
Ras related clinical trials* against pancreatic cancer | Download Table
Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC) - ScienceDirect
Metastatic Pancreatic Cancer: ASCO Guideline Update | Journal of Clinical Oncology
Metastatic Pancreatic Cancer: ASCO Guideline Update | Journal of Clinical Oncology
The Changing Pancreatic Cancer Clinical Trials Landscape – Pancreatic Cancer Action Network
New therapeutic targets in pancreatic cancer - Cancer Treatment Reviews
NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors - European Journal of Cancer
